Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections-Reference-Cited by-同舟云学术

Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections

Published:2016-02 Issue:2 Volume:47 Page:124-131
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Lamoureux Fabien,Duflot Thomas,Woillard Jean-Baptiste,Metsu David,Pereira Tony,Compagnon Patricia,Morisse-Pradier Hélène,El Kholy Mona,Thiberville Luc,Stojanova Jana,Thuillez Christian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?;Owusu Obeng;Pharmacotherapy,2014

2. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations;Smith;Ther Drug Monit,2008

3. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype;Scholz;Br J Clin Pharmacol,2009

4. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing;Dolton;J Antimicrob Chemother,2014

5. Antifungal therapeutic drug monitoring: established and emerging indications;Andes;Antimicrob Agents Chemother,2009

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WHICH TOOL IS THE BEST GUIDE OPTIMIZE THE VORICONAZOLE DOSAGE: THERAPEUTIC DRUG MONITORING OR CYTOCHROME P450 POLYMORPHISM?;Sağlık Bilimleri Dergisi;2024-07-25

2. Stability and Analytical Characterization of Voriconazole as Measured by Immunoassay;J APPL LAB MED;2024

3. Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients;PLOS ONE;2023-09-11

4. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals;Frontiers in Genetics;2023-08-24

5. Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data;Clinical Pharmacokinetics;2023-08-21